InvestorsHub Logo
Followers 84
Posts 12535
Boards Moderated 0
Alias Born 07/25/2008

Re: DonShimoda post# 6614

Tuesday, 03/29/2011 10:29:45 AM

Tuesday, March 29, 2011 10:29:45 AM

Post# of 80490
Don, can we add what Harvey said, "the release of information on new indications for all three of their compounds. Today, we just had the release for the pan-FGFR inhibitor for Pona, which is one. '113 will have one beyond NSCLC, and Rida will have another..
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.